Editas Medicine Inc (EDIT)
2.44
+0.07
(+2.95%)
USD |
NASDAQ |
Nov 22, 16:00
2.435
0.00 (0.00%)
After-Hours: 20:00
Editas Medicine Stock Buybacks (Quarterly): 0.00 for Sept. 30, 2024
Stock Buybacks (Quarterly) Chart
Historical Stock Buybacks (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 0.00 |
June 30, 2024 | 0.00 |
March 31, 2024 | |
December 31, 2023 | 0.00 |
September 30, 2023 | 0.00 |
June 30, 2023 | -117.08M |
March 31, 2023 | |
December 31, 2022 | 0.00 |
September 30, 2022 | 0.00 |
June 30, 2022 | 0.00 |
March 31, 2022 | |
December 31, 2021 | -0.001M |
September 30, 2021 | 0.00 |
June 30, 2021 | 0.011M |
March 31, 2021 | -249.47M |
December 31, 2020 | 0.113M |
September 30, 2020 | 0.125M |
June 30, 2020 | -203.96M |
March 31, 2020 | 0.00 |
Date | Value |
---|---|
December 31, 2019 | -75.12M |
September 30, 2019 | -41.22M |
June 30, 2019 | 0.00 |
March 31, 2019 | |
December 31, 2018 | -28.32M |
September 30, 2018 | 0.00 |
June 30, 2018 | 0.003M |
March 31, 2018 | -48.47M |
December 31, 2017 | -57.46M |
September 30, 2017 | 0.00 |
June 30, 2017 | 0.417M |
March 31, 2017 | -97.10M |
December 31, 2016 | 0.00 |
September 30, 2016 | 0.196M |
June 30, 2016 | 0.498M |
March 31, 2016 | -98.18M |
December 31, 2015 | -0.004M |
September 30, 2015 | -0.002M |
Stock Buyback Definition
Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.
Stock Buybacks (Quarterly) Range, Past 5 Years
-249.47M
Minimum
Mar 2021
0.125M
Maximum
Sep 2020
-37.96M
Average
--
Median
Mar 2020
Stock Buybacks (Quarterly) Benchmarks
Ionis Pharmaceuticals Inc | -496.10M |
EyePoint Pharmaceuticals Inc | -11.79M |
Cassava Sciences Inc | -- |
Adverum Biotechnologies Inc | 0.00 |
Regenxbio Inc | -0.246M |